Nasopharyngeal Carcinoma by AJCC v8 Stage

Nasopharyngeal Carcinoma by AJCC v8 Stage — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 4
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06509009	Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma	recruiting	Phase 2	30	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	Sep 19, 2025	clinicaltrials

Data updated 23 days agoSource updated Sep 19, 2025source: clinicaltrials